Toyota (TM.US) sales in China dropped by 23% in August, marking the seventh consecutive monthly decline in global sales
Toyota’s sales have declined for the seventh consecutive month.
According to information from Zhihong Finance APP, Toyota Motor (TM.US) saw its car sales decline again last month due to sluggish sales in China. In China, traditional car brands are facing increasingly fierce competition from the rapid rise of local electric vehicle manufacturers. This marks the seventh consecutive month of declining sales for Toyota.
On Tuesday, Toyota stated that in August, Toyota and Lexus sales in China, the world's largest auto market, plummeted by 23%, mainly due to weak demand for gasoline and hybrid vehicles. This dragged down the company's global group deliveries by 7.5% year-on-year.
Toyota and its peers have been grappling with sluggish sales in China. In addition, automakers are also facing issues such as uneven demand for electric vehicles and surging oil prices triggered by conflicts in the Middle East.
Driven by strong demand for new models (especially hybrids), Toyota and Lexus sales grew 2.6% in Europe and 9.1% in Japan. In the United States, sales fell by 4.4%; in the Middle East, sales dropped by more than a third.
Earlier this year, Toyota stated that its hybrid vehicle sales are expected to exceed 5 million units for the first time in 2026. Alternative powertrains have provided strong support for the Japanese automaker in the U.S. market, while high U.S. tariffs have made it difficult for some brands to enter this market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Source Agriventures (SRAV.US) aims for Nasdaq: With only one 158-acre farm under its name, can it collect rent from AI data centers?
Source Agriventures submitted a filing to the SEC on Monday, seeking to raise up to 15 million USD through an IPO.
Insimbi swings to interim EPS of 4.52-5.06 cents from 2.69-cent loss per share
Sustainable product manufacturer Med-X (MXRX.US) files for direct listing on Nasdaq
Sustainable product manufacturer Med-X filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday to register its shares and complete a direct listing on Nasdaq.
